Literature DB >> 23325515

Health-related quality of life at median 12 months after aneurysmal subarachnoid hemorrhage, measured with EuroQoL-5D.

Elisabeth Ronne-Engström1, Per Enblad, Erik Lundström.   

Abstract

BACKGROUND: A measurement of quality of life (QoL) should cover the important aspects of daily life and be easy to perform. Ease of performance is especially important for patients with spontaneous subarachnoid haemorrhage (SAH), since fatigue and cognitive disabilities are known sequeles. EuroQoL (EQ-5D) is a preference-based instrument measuring QoL, based on self-reported health status in five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort and Anxiety/Depression. In the present study EuroQoL was used in patients with aneurysmal SAH (aSAH) in comparison with a Swedish reference population. We also determined the extent to which demographic characteristics and clinical parameters predicted outcome.
METHODS: Seven hundred fifty-five patients with aSAH were studied after a median 12 months. The proportion of patients in the best QoL category for each dimension was compared with the corresponding proportion in an age matched reference population. Disease severity was measured using the World Federation of Neurosurgical Societies' SAH grading system and the Fisher scale. The extent to which demographic and clinical factors predicted outcome was evaluated using linear regression.
RESULTS: Aneurysmal SAH patients generally had a worse QoL compared with the reference population, in all five dimensions of EQ-5D. In the patient population, disease severity predicted worse outcome in all five dimensions. Female gender and surgery as treatment method (in the case of anterior aneurysms) predicted worse outcome in Usual Activities and Anxiety/Depression.
CONCLUSION: The nature of the sequeles after SAH depends on severity of disease, gender and treatment method. These factors should be more emphasised in planning rehabilitation.

Entities:  

Mesh:

Year:  2013        PMID: 23325515     DOI: 10.1007/s00701-012-1612-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  3 in total

1.  The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study.

Authors:  Sumithra Giritharan; Joanna Cox; Calvin J Heal; David Hughes; Kanna Gnanalingham; Tara Kearney
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

2.  Serum S100B correlates with health-related quality of life and functional outcome in patients at 1 year after aneurysmal subarachnoid haemorrhage.

Authors:  Helena Aineskog; Conny Johansson; Robert Nilsson; Lars-Owe D Koskinen; Peter Lindvall
Journal:  Acta Neurochir (Wien)       Date:  2022-06-24       Impact factor: 2.816

3.  Outcome from spontaneous subarachnoid haemorrhage--results from 2007-2011 and comparison with our previous series.

Authors:  Elisabeth Ronne-Engström; Ljubisa Borota; Raj Kothimbakam; Niklas Marklund; Anders Lewén; Per Enblad
Journal:  Ups J Med Sci       Date:  2013-10-23       Impact factor: 2.384

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.